{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:39:30Z","timestamp":1778657970652,"version":"3.51.4"},"reference-count":24,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDS"],"published-print":{"date-parts":[[2019,9,17]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Adverse drug reactions (ADRs) due to antiepileptic drugs (AEDs) in children\ncontribute to poorer patient outcomes. However, reliable data ragarding such ADRs is not\navailable.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objectives:<\/jats:title>\n<jats:p>Thus, the aim of the present study was to determine the incidence and patterns of ADRs\nof antiepileptic drugs in children aged 2-17 years presenting to a tertiary care teaching hospital.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>An observational study was conducted in the Department of Pediatrics, Kalawati Saran\nChildren\u2019s Hospital for a period of one year. Two hundred consecutive eligible patients (aged 2-17\nyrs with epilepsy on AED) with consenting parents were enrolled. ADRs were noted using Paediatric\nEpilepsy Side Effect Questionnaire (PESQ) at clinic visits and any other ADRs reported by parents\nwere also recorded. Causality, severity and avoidability assessments were done.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> The mean age was 10.5 \u00b1 3.6 years. A total of 139 ADRs occurred in 97 patients. One\nhundred and nine ADRs were reported by use of PESQ, in addition, 30 ADRs were reported by parents.\nPoor school result (33.8%) was the commonest ADR. Valproate (61.9%) was the main drug\ncausing ADRs. Valproate, when used in polytherapy, was associated with more number of children\nexperiencing ADRs (72.2%). The most common add on drug was clobazam (42.3%). Children with\npoorly controlled epilepsy were associated with more ADRs. Causality assessment revealed that\n91.3% of the ADRs were probable. Most (94.9%) ADRs were of \u2018mild\u2019 category and 95.7% were\nprobably preventable. Treatment was discontinued only in 6 patients of phenytoin toxicity.R<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Cognitive and neurological problems were the most common ADRs seen in children\nwith epilepsy. Polytherapy significantly increases the likelihood of ADRs in children.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1574886314666190311112710","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T10:54:03Z","timestamp":1552301643000},"page":"217-224","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Adverse Drug Reactions of Anti-Epileptic Drugs in Children with Epilepsy: A Cross-Sectional Study"],"prefix":"10.2174","volume":"14","author":[{"given":"Sundeep","family":"Kaushik","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Charak Palika Hospital, Moti Bagh NDMC, New Delhi-110021, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepti","family":"Chopra","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Government Institute of Medical Sciences, Kasna, Greater Noida, UP 201310, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suvasini","family":"Sharma","sequence":"additional","affiliation":[{"name":"Neurology Division, Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children's Hospital, New Delhi, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satinder","family":"Aneja","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, School of Medical Sciences & Research, Sharda University, Greater Noida, UP 201310, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1528-1157.1999.tb02072.x","volume":"40","author":"Radhakrishnan K.","year":"1999","unstructured":"Radhakrishnan K.; Dinesh N.S.; Pradeep K.S.; Sankara S.P.; Profile of antiepileptic pharmacotherapy in a tertiary referral centre in South India: A pharmacoepidemiologic and pharmacoeconomic study. Epilepsia 1999,40,179-185","journal-title":"Epilepsia"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0404.2005.00506.x","volume":"112","author":"Perucca E.","year":"2005","unstructured":"Perucca E.; Meador K.J.; Adverse effects of antiepileptic drugs. Acta Neurol Scand 2005,112(181),30-35","journal-title":"Acta Neurol Scand"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1136\/adc.87.6.462","volume":"87","author":"Clarkson A.","year":"2002","unstructured":"Clarkson A.; Choonara I.; Surveillance for fatal suspected adverse drug reactions in the UK. Arch Dis Child 2002,87,462-466","journal-title":"Arch Dis Child"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1542\/peds.2005-2429","volume":"118","author":"Le J.","year":"2006","unstructured":"Le J.; Nguyen T.; Law A.V.; Hodding J.; Adverse drug reactions among children over a 10-year period. Pediatrics 2006,118,555-562","journal-title":"Pediatrics"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/adc.2009.165902","volume":"95","author":"Anderson M.","year":"2010","unstructured":"Anderson M.; Choonara I.; A systematic review of safety monitoring and drug toxicity in published randomised controlled trials of antiepileptic drugs in children over a 10-year period. Arch Dis Child 2010,95,731-738","journal-title":"Arch Dis Child"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/WNF.0b013e31829a498d","volume":"36","author":"Bansal D.","year":"2013","unstructured":"Bansal D.; Azad C.; Kaur M.; Rudroju N.; Vepa P.; Guglani V.; Adverse effects of antiepileptic drugs in North Indian pediatric outpatients. Clin Neuropharmacol 2013,36,107-113","journal-title":"Clin Neuropharmacol"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1212\/WNL.0b013e3182635b87","volume":"79","author":"Morita D.A.","year":"2012","unstructured":"Morita D.A.; Glauser T.A.; Modi A.C.; Development and validation of the pediatric epilepsy side effects questionnaire. Neurology 2012,79,1252-1258","journal-title":"Neurology"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"Naranjo C.A.","year":"1981","unstructured":"Naranjo C.A.; Busto U.; Sellers E.M.; A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981,30,239-4","journal-title":"Clin Pharmacol Ther"},{"key":"ref=9","first-page":"2229","volume":"49","author":"Hartwig S.C.","year":"1992","unstructured":"Hartwig S.C.; Siegel J.; Schneider P.J.; Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992,49,2229-2232","journal-title":"Am J Hosp Pharm"},{"key":"ref=10","first-page":"538","volume":"27","author":"Schumock G.T.","year":"1992","unstructured":"Schumock G.T.; Thornton J.P.; Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992,27,538","journal-title":"Hosp Pharm"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"139S","DOI":"10.1592\/phco.20.12.139S.35255","volume":"20 Pt 2","author":"Cloyd JC","year":"2000","unstructured":"Cloyd JC; Remmel RP; Antiepileptic drug pharmacokinetics and\n\tinteractions: Impact on treatment of epilepsy. Pharmacotherapy 2000,20 Pt 2(8),139S-51S","journal-title":"Pharmacotherapy"},{"key":"ref=12","first-page":"703","volume":"120","author":"Foletti G.B.","year":"2000","unstructured":"Foletti G.B.; Clinical utilization of new anti-epileptic agents. Rev Med Suisse Romande 2000,120,703-707","journal-title":"Rev Med Suisse Romande"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2710.2000.00271.x","volume":"25","author":"Chen L.C.","year":"2001","unstructured":"Chen L.C.; Chen Y.F.; Yang L.L.; Chou M.H.; Lin M.F.; Drug utilization pattern of antiepileptic drugs and traditional Chinese medicines in a general hospital in Taiwan - a pharmaco-epidemiologic study. J Clin Pharm Ther 2001,25,125-129","journal-title":"J Clin Pharm Ther"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1528-1157.1995.tb00484.x","volume":"36","author":"Lammers M.W.","year":"1995","unstructured":"Lammers M.W.; Hekster Y.A.; Keyser A.; Meinardi H.; Renier W.O.; van Lier H.; Monotherapy or polytherapy for epilepsy revisited: A quantative assessment. Epilepsia 1995,36,440-446","journal-title":"Epilepsia"},{"key":"ref=15","first-page":"1561","volume":"4","author":"Ramya A.","year":"2015","unstructured":"Ramya A.; Sravya P.; Kumar V.; Reddy T.; Lakhshmi C.; Pediatric Seizures \u2013 a prospective study on drug utilization pattern and its outcome in a teritiary Care Hospital. World J Pharmaceutical Res 2015,4,1561-1572","journal-title":"World J Pharmaceutical Res"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"e008298","DOI":"10.1136\/bmjopen-2015-008298","volume":"5","author":"Anderson M.","year":"2015","unstructured":"Anderson M.; Egunsola O.; Cherrill J.; Millward C.; Fakis A.; Choonara I.; A prospective study of adverse drug reactions to antiepileptic drugs in children. BMJ Open 2015,5(6),e008298","journal-title":"BMJ Open"},{"key":"ref=17","first-page":"504","volume":"3","author":"Kousalya K.","year":"2014","unstructured":"Kousalya K.; Swathi Cherukuri D.P.; Padmasani L.N.; Arun Prasath T.S.; Drug utilization pattern of antiepileptics and their adverse effects in pediatrics. World J Pharmaceutical Res 2014,3(9),504-513","journal-title":"World J Pharmaceutical Res"},{"key":"ref=18","first-page":"55","volume":"3","author":"Mathur S.","year":"2010","unstructured":"Mathur S.; Sen S.; Ramesh L.; Kumar S.; Utilization pattern of antiepileptic drugs and their adverse effects in a teaching hospital. Asian J Pharm Clin Res 2010,3,55-60","journal-title":"Asian J Pharm Clin Res"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vhri.2014.07.009","volume":"6","author":"George J.","year":"2015","unstructured":"George J.; Chanda K.; Sharma G.R.K.; Antiepileptic drugs and quality of life in patients with epilepsy: A Tertiary Care Hospital-based study. Value Health Reg Issues 2015,6,1-6","journal-title":"Value Health Reg Issues"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.5455\/2319-2003.ijbcp20140415","volume":"3","author":"Mistry R.A.","year":"2014","unstructured":"Mistry R.A.; Solanki K.C.; Prajapati H.K.; Doshi T.M.; Trivedi H.R.; Drug utilization pattern of antiseizure drugs and their adverse effects in the pediatric population, in a tertiary care hospital attached to a medical college. Int J Basic Clin Pharmacol 2014,3,336-342","journal-title":"Int J Basic Clin Pharmacol"},{"key":"ref=21","first-page":"25","volume":"7","author":"Karimzadeh P.","year":"2013","unstructured":"Karimzadeh P.; Bakrani V.; Antiepileptic Drug-Related Adverse Reactions and factors influencing these reactions. Iran J Child Neurol 2013,7,25-29","journal-title":"Iran J Child Neurol"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/0253-7613.106443","volume":"45","author":"Gosavi D.D.","year":"2013","unstructured":"Gosavi D.D.; Suman A.; Jain M.; Sodium valproate induced increased frequency of micturition and enuresis. Ind J Pharmacol 2013,45,87-88","journal-title":"Ind J Pharmacol"},{"key":"ref=23","first-page":"1671","volume":"9","year":"2013","unstructured":"23 Cheng W, Lin X, Lu D. Sodium valproate-induced enuresis in a pediatric bipolar patient. Neuropsychiatr Dis Treat 2013,9,1671-1672","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.yebeh.2015.03.014","volume":"45","author":"Junger K.W.","year":"2015","unstructured":"Junger K.W.; Morit D.; Modi A.C.; The pediatric epilepsy side effects questionnaire: Establishing clinically meaningful change. Epilepsy Behav 2015,45,101-104","journal-title":"Epilepsy Behav"}],"container-title":["Current Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/170601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T16:11:49Z","timestamp":1571415109000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/170601\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,17]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9,17]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1574886314666190311112710","relation":{},"ISSN":["1574-8863"],"issn-type":[{"value":"1574-8863","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,17]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-01-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-02-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-09-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}